Table 1.
Baseline characteristics.
| MOC (n = 1419) |
Control (n = 5116) |
p-value | |
|---|---|---|---|
| Age | 64.2 (14) | 69.7 (13) | <0.001 |
| Female sex | 449 (31.6 %) | 1616 (31.6 %) | 0.969 |
| Race | 0.002 | ||
| White | 1184 (83.4 %) | 4446 (86.9 %) | |
| Black | 194 (13.7 %) | 572 (11.2 %) | |
| Other | 41 (2.9 %) | 98 (1.9 %) | |
| Hypertension | 946 (66.7 %) | 4001 (78.2 %) | <0.001 |
| Dyslipidemia | 859 (60.5 %) | 3742 (73.1 %) | <0.001 |
| Diabetes mellitus | 432 (30.4 %) | 1872 (36.6 %) | <0.001 |
| Ischemic heart disease | 269 (19 %) | 1274 (24.9 %) | <0.001 |
| Myocardial infarction | 125 (8.8 %) | 710 (13.9 %) | <0.001 |
| Stroke | 178 (12.5 %) | 855 (16.7 %) | <0.001 |
| Transient ischemic attack | 54 (3.8 %) | 230 (4.5 %) | 0.259 |
| Peripheral vascular disease | 137 (9.6 %) | 696 (13.6 %) | <0.001 |
| Deep vein thrombosis | 69 (4.9 %) | 245 (4.8 %) | 0.909 |
| Pulmonary embolism | 55 (3.9 %) | 226 (4.4 %) | 0.374 |
| Major bleeding | 251 (17.7 %) | 1040 (20.3 %) | 0.027 |
| Atrial fibrillation | 412 (29 %) | 1986 (38.8 %) | <0.001 |
| Ventricular tachycardia/ventricular fibrillation | 16 (1.1 %) | 81 (1.6 %) | 0.209 |
| Cardiac arrest | 22 (1.6 %) | 87 (1.7 %) | 0.696 |
| Chronic kidney disease | 164 (11.6 %) | 974 (19 %) | <0.001 |
| End-stage renal disease | 20 (1.4 %) | 118 (2.3 %) | 0.038 |
| Chronic obstructive pulmonary disease | 196 (13.8 %) | 903 (17.6 %) | <0.001 |
| Obstructive sleep apnea | 290 (20.4 %) | 1114 (21.8 %) | 0.278 |
| Left ventricular ejection fraction | 30.4 (11.1) | 26.5 (7.4) | <0.001 |
Continuous data expressed as mean (SD).
Categorical data expressed as n (%).